Stock Price Quote

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE350.800.1 (+0.03 %)
PREV CLOSE ( ) 350.70
OPEN PRICE ( ) 350.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 34894
TODAY'S LOW / HIGH ( )349.75 355.85
52 WK LOW / HIGH ( )267.3 667
NSE350.75-0.15 (-0.04 %)
PREV CLOSE( ) 350.90
OPEN PRICE ( ) 349.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1121453
TODAY'S LOW / HIGH( ) 349.10 356.00
52 WK LOW / HIGH ( )267.25 666.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1977
Management Info
Glenn Saldanha - Chairman Glenn Saldanha - Managing Director
Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

14Jan Re
This is in furtherance to our letter dated May 29, 2019 whereby we had i..
14Jan Glenmark Pharmaceuticals informs about
In furtherance to letter dated May 29, 2019 whereby it had informed the..
14Jan Fitch Ratings assigns rating to Glenma
Credit rating agency -- Fitch Ratings has assigned Glenmark Pharmaceutic..
07Jan Glenmark’s arm gets final USFDA’s nod
Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., U..
07Jan Glenmark soars as its arm gets final U
Glenmark Pharmaceuticals is currently trading at Rs. 345.65, up by 6.00..

Financials

in Millions
QTR Sep 19 ANNUAL 19
Net Profit4319.9216221.12
Gross Profit 4745.07 18181.84
Operating Profit 5729.9618030.92
Net Sales 17898.1963048.67

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4165.75 (2.76%)
M.Cap ( in Cr)19057.36
Alkem Laboratories (BSE)
peergroup  2351.55 (0.95%)
M.Cap ( in Cr)28116.31
Aarti Drugs (BSE)
peergroup  622.85 (3.43%)
M.Cap ( in Cr)1451.24
Themis Medicare (BSE)
peergroup  413.95 (5.00%)
M.Cap ( in Cr)380.05
Wockhardt (BSE)
peergroup  299.05 (6.44%)
M.Cap ( in Cr)3311.53

Shareholding Pattern

PROMOTERS 46.59%
MUTUAL FUNDS/UTI 4.07%
FI/BANKS/INSURANCE 2.97%
NON-INSTITUTION 16.21%
GOVERNMENT 0%
FII 0%

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 18-11-1977. Its today's share price is 350.8. Its current market capitalisation stands at Rs 9898.46 Cr. In the latest quarter, company has reported Gross Sales of Rs. 70091.65 Cr and Total Income of Rs.74847.79 Cr. The company's management includes Saira Ramasastry, Harish Kuber, D R Mehta, Milind Sarwate, Julio F Ribeiro, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X